| study cohort |
cohort |
129 |
63 |
1,139 baseline participants, 1,148 persons, 1,953 patients, 14 alcoholic and 13 control cases, 15 probands and family members, 17,355 subjects, 188 subjects, 189 subjects, 19 participants, 2134 families, 23 laboratories cohort, 26 cohorts, 27 cases, 3,112 individuals, 3,315 individuals, 3,378 individuals, 3,816 individuals, 3.2 million individuals, 353 participants, 3589 individuals, 4,385 individuals, 410 subjects, 449 subjects, 50,222 subjects, 535 samples, 5441 individuals, 69 subjects, 766 subjects, Cohort 2, Diabetes Heart Studies, GWAS, N=406 men, Nr, Participants, Participants (n=1023), age at interview cohort, age cohort, clinical population of over 20,000 patients, cohort, cohort 1, cohort 2, cohort 3, cohort 4, cohort 5, cohort 6, cohort [19], cohort studies, cohort-level summary statistics, cohort-sequential approach, cohort1, cohort2, cohort3, cohort4, cohort5, cohort6, cohorts, depressed patients, eight cohorts, entire cohort, first cohort, genome-wide association scan, independent cohort, large cohort, large cohorts, multiple studies, original cohort, other cohorts, our cohorts, our students, our study cohort, participants, patient sample, patients, project, replication cases, replication sample, replication samples, sample, schizophrenia organoids, second cohort, seven studies, six additional cohorts, subjects, subjects from our study, the cohort, the study, these cohorts, this population, this study, total sample, working group dataset, younger panel, youngest cohort |
| Study of Addiction: Genetics and Environment |
cohort |
13 |
4 |
SAGE |
| subclonal mutations |
variant |
2 |
1 |
subclonal driver mutations |
| subjective well-being |
phenotype |
19 |
10 |
WELL-BEINGdi, Well-Beingdi, average levels of well-being, daily well‑being, subjective well-being, well-being, well‑being |
| subjects |
cohort |
33 |
7 |
Study participants, all subjects, individuals, overall sample of subjects, participants, subjects |
| sub-saharan Africa |
cohort |
2 |
2 |
SSA |
| substance abuse |
phenotype |
77 |
54 |
SUD, SUDs, abuse, abuser, abuser vs control, addiction, alcohol abuse, alcohol and drug abuse, compulsive substance abuse, drug abuse, substance abuse, substance abuse disorders, substance abuse problems, substance abuse risk, substance abuse/dependence, substance abuser, substance involvement, substance use, substance use disorder, vulnerability to substance abuse |
| substances |
phenotype |
20 |
8 |
adolescent substance use, major classes of substances, peers who also report substance use, substance classes, substances, substances to relieve PTSD symptoms |
| substance use |
phenotype |
217 |
164 |
ASUD, DSM-5 SUD, DSM-IV SUD, DSM‑IV diagnosis of substance dependence, F10-F19, SD, SD disorders, SD traits, SDI, SDs, SUD, SUD diagnoses, SUD risk, SUDs, Substance Use Disorder, Substance Use Disorders (SUDs), Substance use, abuse/dependence on alcohol or another substance, addiction, addictive disorders, adolescent substance use, adolescents' own substance use, adult substance use, age of substance use initiation, alcohol and other drug use disorders, any substance, co-occurring substance dependence, comorbid SD, current SUDs, dependence, dependence diagnoses, dependence on addictive substances, dependent, dependent individuals, dependent on illicit substances, disorder, drug abuse, drug dependence, drug use, drug use disorders, drug-addicted individuals, early adolescent substance use problems, early substance initiation, early substance involvement, family history of a substance use disorder, frequency of substance use, general susceptibility to develop a substance use disorder, human substance dependence, initiation, initiation of drug use, initiation of substance use, later disorder, lifetime SUD diagnoses, maternal substance use during pregnancy, misuse, new or ongoing SUD, other substance use, other substance use disorder, other substance use disorders, other substances, overall prevalence of substance use, overall substance use disorders, parental substance dependence, parents with substance use disorders, past-month use, past-year substance use disorder, paternal substance dependence, peer substance involvement, problematic patterns of use, regular use, relapse to substance use, substance, substance abuse, substance abuse/dependence, substance consumption, substance dependence, substance dependence diagnoses, substance dependence traits, substance dependencies, substance dependent, substance dependent samples, substance factor, substance involvement, substance misuse, substance misusers, substance use, substance use among close friends, substance use and abuse, substance use behavior, substance use behaviors, substance use disorder, substance use disorders, substance use factor, substance use in general, substance use initiation, substance use items, substance use later in life, substance use outcomes, substance use phenotype, substance use phenotypes, substance use problems, substance use problems in adolescents, substance use variables, substance users, substance-dependent, substance-dependent individuals, substance-related behaviors, substance-related problems, substance-use, substance-use disorders, timing of substance use initiation, treatment of substance dependence, use of any substance, use of substances, vulnerability to dependence, youth use of any substance |
| substance use outcomes |
phenotype |
2 |
1 |
substance use |
| substance use phenotypes |
phenotype |
3 |
3 |
Substance use |
| Successful quitting |
phenotype |
6 |
3 |
one-year sustained abstinence, quit attempt success |
| success rate |
phenotype |
3 |
1 |
|
| sucrose |
drug |
27 |
12 |
10% sucrose, 2% sucrose solution, 30% sucrose, 30% sucrose solution, 7% sucrose, table sugar |
| Sucrose Cushion Buffer I |
drug |
3 |
2 |
|
| SUD |
phenotype |
21 |
18 |
DSM-5 criteria for SUDs, SUD, SUDs, Substance Use Disorder, Substance Use Disorders, Substance use disorder, Substance use disorders, addiction, drug abuse, parental SUD, substance use, substance use disorder, substance use disorders |
| SUD criterion counts |
phenotype |
2 |
2 |
SUD criteria, Substance Use Disorder criterion counts, substance use disorder criteria |
| SUI |
phenotype |
2 |
1 |
Suicidal Ideation, Suicide Attempt, suicide attempt |
| suicide |
phenotype |
65 |
49 |
IDE, SA, SB, SI, SUI, Suicide, Suicide attempt/s, attempted suicide, completed suicide, death by suicide, history of suicide attempts, individuals who died by suicide, lifetime occurrence of suicidal thoughts, lifetime suicidal ideation, lifetime suicide attempt, lifetime suicide attempts, past 12 months suicidal ideation, recent suicidal intent, suicidal behavior, suicidal ideation, suicidal plan, suicidal thoughts, suicidal thoughts and attempts, suicidality, suicide, suicide attempt, suicide attempters, suicide attempts, suicide completers, suicide death, suicide deaths, suicide decedents, suicide ideation, suicide plan, suicide rate, suicide rates, suicide risk, suicide-death, unplanned suicide attempts |
| suicide outcomes |
phenotype |
2 |
— |
suicide |
